Weight-loss drugs like Ozempic and Zepbound appear to reduce alcohol cravings, but doctors have been at a loss to explain why -- until now.
Glucagon-like peptide-1 drugs appear to slow the speed at which alcohol enters the bloodstream, which also diminishes its effects on a person's brain, pilot study results published Wednesday in the journal Scientific Reports indicate.
Essentially, people don't feel the effects of alcohol as intensely if they're taking a GLP-1 med, researchers said.
"People who drink know there's a difference between nursing a glass of wine and downing a shot of whiskey," researcher Alex DiFeliceantonio said in a news release. She's interim co-director of the Roanoke, Virginia-based Fralin Biomedical Research Institute at VTC's Center for Health Behaviors Research.
Related
